Unitaid's $140m to ease market access for firms developing affordable POC HIV diagnostics
This article was originally published in Clinica
Executive Summary
Unitaid, the global health initiative tackling HIV/AIDS, malaria and tuberculosis, is investing over $140m to fund projects that would widen access to affordable point-of-care HIV diagnostics in Africa, as well as companies developing these types of technologies.